CIRAS News, Fall 2012, Vol. 48, no. 1

CIRAS is to enhance the performance of Iowa industry, and associated entities, through education and technology-based services. This newsletter holds information regarding these services.

1.48 and 1.84 µm thulium emissions in monoclinic KGd(WO4)2 single crystals

By exciting at 788 nm, we have characterized the near infrared emissions of trivalent thulium ions in monoclinic KGd(WO4)2 single crystals at 1.48 and 1.84 mm as a function of dopant concentration from 0.1% to 10% and temperature from 10 K to room temperature. We used the reciprocity method to calculate the maximum emission cross-section of 3.0310220 cm2 at 1.838 mm for the polarization parallel to the Nm principal optical direction. These results agrees well with the experimental data. Experimental decay times of the 3H4!3F4 and 3F4!3H6 transitions have been measured as a function of thulium concentration.

Kansanhuoltoministeriö 15.1.48

17 x 25 cm

Folkförsörjningsministeriet 15.1.48

17 x 25 cm

[Topografičeskaâ karta 1:42000]. XV-47, XV-48, XIV-47, XIV-48, Vyborg. gub., uězdy Âski, Stranda i Vil'manstr. / snimal" i c̆ertil" Lazarevskìj.

[1:42000].

[Topografičeskaâ karta 1:42000]. IX-47, IX-48, VIII-47, VIII-48, Vyborgskoj gubernìû uĕzda Stranda / snimali i c̆ertili Strebâlov" i Polâkov".

[1:42000].

[Topografičeskaâ karta 1:42000]. VII-48, VII-49, Vyb. gub., Strandsk. u / snimal" i čertil" Rožickìj.

1:42000.

Archives parlementaires de 1787 à 1860 ; 34-51. Assemblée nationale législative. Série 1 / Tome 48 / impr. par ordre du Sénat et de la Chambre des députés ; sous la dir. de M. J. Mavidal,... et de M. E. Laurent,... ; avec la collab. de MM. E. Tonnier et C. Pionnier

Collection : Les archives de la Révolution française ; 3.1

Níveis de endotelina-1 no sangue do cordão umbilical e com 12 a 48 horas de vida em recém-nascidos pré-termo com e sem doença da membrana hialina

Objetivo: Determinar os níveis da endotelina-1 (ET-1) no sangue de cordão umbilical e no plasma de recém-nascidos pré-termo com doença da membrana hialina (DMH) e comparar estes níveis com controles. Metodologia: Nós determinamos os níveis da ET-1 em 18 pré-termos com DMH que não tiveram diagnóstico clínico ou ecocardiográfico de hipertensão pulmonar e em 22 prétermos sem DMH (peso de nascimento < 2000g e idade gestacional ≤ 34 semanas). Foram utilizados sangue do cordão umbilical e uma segunda amostra de sangue coletada durante as primeiras 12 a 48 horas de vida após o nascimento, para determinação da ET-1 por enzimoimunoensaio. Resultados: As medianas dos valores da ET-1 do sangue de cordão umbilical foram similares nos dois grupos (controles: 10,9pg/mL e DMH: 11,4pg/mL) e foram significativamente maiores do que as da segunda amostra (controles: 1,7pg/mL, DMH: 3,5pg/mL; p<0,001 para ambos os grupos). As medianas da ET-1 da segunda amostra foram significativamente maiores no grupo com DMH do que no grupo controle (p<0,001). Houve uma correlação positiva entre dosagem da ET-1 na segunda amostra e o Escore de Gravidade Neonatal SNAPPE II (r=0,36, p=0,02), e duração da ventilação mecânica (r=0,59, p=0,04). Um declíneo mais lento nos valores da ET-1 do nascimento para as 12 a 48h de vida foi observado nos recém-nascidos pré-termo com DMH comparados com os controles. Conclusões: Recém-nascidos pré-termo com e sem DMH tem níveis semelhantes da ET-1 no sangue de cordão umbilical, enquanto os níveis da ET-1 no recém-nascido com 12 a 48 horas de vida foram maiores nos com DMH do que nos controles. Níveis elevados da ET-1 na DMH sugerem que este mediador está envolvido na fisiopatologia da DMH.

The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1

Peginterferon-alpha plus ribavirin is the most effective therapy for chronic hepatitis C. This study was designed to evaluate the effect of peginterferon alpha-2a (40 kDa) plus ribavirin on sustained virological response (SVR) when administered for 24 vs 48 weeks in genotype 1 naive patients. One hundred and seventeen patients were enrolled in this controlled trial. Genotype 1 patients were randomized to 24 weeks treatment vs 48 weeks treatment. Genotype non-1 patients received 24 weeks treatment as an observational group. Outcomes were SVR (defined by hepatitis C virus-RNA-negative at week 24 of follow-up) and tolerability across the study period. The end-of-treatment response was 59% for genotype 1 (24 weeks treatment), 80% for genotype 1 (48 weeks treatment) and 92% for genotype non-1 (24 weeks treatment). The end-of-follow-up response was 19% (95% confidence interval (CI): 7.2-36.4) (genotype 1, 24 weeks) and 48% (95% CI: 30.2-66.9; P = 0.0175) (genotype 1, 48 weeks). Among genotype non-1, SVR was 76% (95% CI: 62.3-86.5). There were no unexpected adverse events.Almost half of the genotype 1 patients achieved an SVR after 48 weeks treatment with peginterferon alpha-2a (40 kDa) and low-dose ribavirin and confirmed that they should be treated for 48 weeks. Safety profile was acceptable.

Frequency upconversion in Er3+-doped fluoroindate glasses pumped at 1.48 μm

We report on efficient frequency upconversion in Er3+-doped fluoroindate glass. The process is observed under 1.48 μm laser diode excitation and results in fluorescence generation in the range from ultraviolet to near-infrared radiation. The study was performed for samples containing 1, 2, and 3 ErF3 mol % in the range of temperatures from 24 to 448 K. The upconverted signals were studied as a function of the laser intensity, and their dynamical behavior is described using a rate equation model which allows us to obtain the energy transfer rates between Er3+ ions in pairs and triads.

Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland

Extensively drug-resistant (XDR) Klebsiella pneumoniae isolates usually carry a single carbapenemase (e.g. KPC, NDM, OXA-48-like). Here we describe an XDR K. pneumoniae of sequence type 101 that was detected in the screening rectal swab of a patient transferred from the intensive care unit of a hospital located in Belgrade (Serbia) to Bern University Hospital (Switzerland). The isolate was resistant to all antibiotics with the exception of colistin [minimum inhibitory concentration] (MIC≤0.125μg/mL), tigecycline (MIC=0.5μg/mL) and fosfomycin (MIC=2μg/mL). The isolate co-possessed class B (NDM-1) and class D (OXA-48) carbapenemases, class A extended-spectrum β-lactamase (CTX-M-15), class C cephalosporinase (CMY-16), ArmA 16S rRNA methyltransferase, substitutions in GyrA and ParC, loss of OmpK35 porin, as well as other genes conferring resistance to quinolones (qnrA), tetracyclines [tet(A)], sulfonamides (sul1, sul2), trimethoprim (dfrA12, dfrA14), rifampicin (arr-1), chloramphenicol (cmlA1, floR) and streptomycin (aadA1). The patient was placed under contact isolation precautions preventing the spread of this nearly untreatable pathogen.